Vue transversale globale

Toutes les maladies

Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.

Périmètre

Filtrer toute la vue

Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.

Tout réinitialiser Actualisation…
Essais et traitements4050Données cliniques et programmes
Recherches et trouvailles21Pipeline scientifique
Publications4595Références reliées aux maladies
Pistes exploratoires0Hypothèses non validées
8666 résultats correspondants · 41 visibles sur cette page dans le périmètre Toutes les maladies
Niveau clinique

Études et traitements 4050

Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
MK-0472 NCT05853367 · Study of MK-0472 in Participants With Advanced/Metastatic Solid Tumors (MK-0472-… Maladie de Parkinson À vérifier Phase 1 ACTIVE_NOT_RECRUITING The purpose of this study is to assess the efficacy, safety, and tolerabil… À vérifier ClinicalTrials.gov 2026-08-13 14:27:55 Détail
Sacituzumab Tirumotecan NCT06841354 · A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Comb… Maladie de Parkinson Thérapie génique Phase 3 RECRUITING Researchers are looking for new ways to treat metastatic cervical cancer.… À vérifier ClinicalTrials.gov 2026-08-13 14:27:55 Détail
Alemtuzumab GZ402673 NCT03368664 · LemKids — A Study to Evaluate Efficacy, Safety, and Tolerability of Alemtuzumab… Sclérose en plaques À vérifier Phase 3 TERMINATED Primary Objective: To evaluate the efficacy, safety, and tolerability of a… À vérifier ClinicalTrials.gov 2026-08-13 14:27:41 Détail
COMBINE — A Novel Combinatory Approach to Maximize Functional Recover… NCT06197685 · NCT06197685 Sclérose en plaques Ralentissement de la progression Non applicable RECRUITING The goal of this novel study is to compare the effect of a combined cognit… À vérifier ClinicalTrials.gov 2026-08-13 14:27:41 Détail
CoQualSEP — Cognitive Disability and Quality of Life of Patients Suff… NCT01392872 · NCT01392872 Sclérose en plaques À vérifier Non applicable COMPLETED Multiple Sclerosis is the first cause of neurological handicap in France.… À vérifier ClinicalTrials.gov 2026-08-13 14:27:41 Détail
Effect of Sensory Integration Therapy on Gait Variability and Quality… NCT07390201 · NCT07390201 Sclérose en plaques À vérifier Non applicable COMPLETED This study aims to evaluate the impact of sensory integration therapy on i… À vérifier ClinicalTrials.gov 2026-08-13 14:27:41 Détail
Ferumoxytol NCT02511028 · In Vivo Characterization of Inflammation With Ferumoxytol, an Ultrasmall Superpa… Sclérose en plaques Immunomodulation Phase 1 COMPLETED Description non affichée : incohérence de maladie détectée. Consultez l’es… À vérifier ClinicalTrials.gov 2026-08-13 14:27:41 Détail
GA Depot NCT04121221 · A Study to Asses Efficacy, Safety and Tolerability of Monthly Long-acting IM Inj… Sclérose en plaques À vérifier Phase 3 COMPLETED A multinational, multicenter, randomized, Phase III, double blind, paralle… À vérifier ClinicalTrials.gov 2026-08-13 14:27:41 Détail
MRI Evaluation NCT03455582 · PRO-COG — Cognition Evolution and MRI Markers in PPMS Patients on 2 Years Sclérose en plaques Immunomodulation Non applicable COMPLETED Cognitive impairment is nowadays more and more recognized as an important… À vérifier ClinicalTrials.gov 2026-08-13 14:27:41 Détail
S103 NCT07587125 · RESET-MS — Safety and Efficacy of S103 Cells in Progressive/Refractory Multiple… Sclérose en plaques Immunomodulation Phase 1 RECRUITING This study is a single-center, open-label, single-arm, exploratory clinica… À vérifier ClinicalTrials.gov NCT07587125 2026-08-13 14:27:41 Détail
Transcranial Direct Current stimulation NCT06401928 · Electrical Brain Stimulation for Treatment of Secondary Symptoms in Multiple Scl… Sclérose en plaques Traitement symptomatique Non applicable COMPLETED Migraine is a common, heterogeneous neurological disorder affecting approx… À vérifier ClinicalTrials.gov 2026-08-13 14:27:41 Détail
[18F] FZTA NCT07115017 · FZTA Pilot — This Study Involves a Positron Emission Tomography (PET) Scan Using… Sclérose en plaques Immunomodulation À vérifier RECRUITING This study involves a Positron Emission Tomography (PET) scan using a new… À vérifier ClinicalTrials.gov 2026-08-13 14:27:41 Détail
Mental Rotation and Motor Imagery Training in Multiple Sclerosis NCT07749690 · NCT07749690 Sclérose en plaques À vérifier Non applicable COMPLETED This randomized controlled trial investigated the effects of sequential la… À vérifier ClinicalTrials.gov 2026-08-13 14:27:40 Détail
Ocrelizumab Test Formulation NCT07074886 · PORTAMENTO — A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulati… Sclérose en plaques À vérifier Phase 2 ACTIVE_NOT_RECRUITING The main purpose of this study is to assess the bioequivalence of ocrelizu… À vérifier ClinicalTrials.gov 2026-08-13 14:27:40 Détail
VAMOS-MS — Delivery of a Culturally Tailored Exercise Training Interv… NCT07606742 · NCT07606742 Sclérose en plaques À vérifier Non applicable RECRUITING The purpose of this study is to establish differences in the primary outco… À vérifier ClinicalTrials.gov 2026-08-13 14:27:40 Détail
WEBCAMS: Walking Exercise for Brain and Cognition in Adults With Mult… NCT05755061 · NCT05755061 Sclérose en plaques À vérifier Phase 1 ACTIVE_NOT_RECRUITING This study is a randomized controlled trial (RCT) that compares the effect… À vérifier ClinicalTrials.gov 2026-08-13 14:27:40 Détail
levetiracetam NCT00324454 · Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease Sclérose latérale amyotrophique Neuroprotection · Traitement symptomatique Phase 2 COMPLETED The purpose of this study is to determine the feasibility, efficacy and sa… À vérifier ClinicalTrials.gov 2026-08-13 14:17:45 Détail
MSC_NTF cells transplantation by multiple intramuscular injections at… NCT01777646 · Autologous Mesenchymal Bone Marrow Stromal Cells Secreting Neurotrophic Factors… Sclérose latérale amyotrophique Thérapie cellulaire Phase 2 COMPLETED Description non affichée : incohérence de maladie détectée. Consultez l’es… À vérifier ClinicalTrials.gov 2026-08-13 14:17:45 Détail
Rapamycin NCT03359538 · RAP-ALS — Rapamycin Treatment for ALS Sclérose latérale amyotrophique Neuroprotection · Ralentissement de la progression Phase 2 COMPLETED Description non affichée : incohérence de maladie détectée. Consultez l’es… À vérifier ClinicalTrials.gov 2026-08-13 14:17:45 Détail
MT-1186 NCT04165824 · Safety Study of Oral Edaravone Administered in Subjects With ALS Sclérose latérale amyotrophique À vérifier Phase 3 COMPLETED Description non affichée : incohérence de maladie détectée. Consultez l’es… À vérifier ClinicalTrials.gov 2026-08-13 14:17:44 Détail
Découverte scientifique

Recherches et trouvailles 21

Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation Sclérose latérale amyotrophique Neuroprotection · Immunomodulation Découverte fondamentale Exploratoire Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… Revue scientifique 2024-07-01 Détail
Bibliographie

Publications 4595

Références bibliographiques de la base locale et accès à leur source originale.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Effects of testosterone-augmented multimodal exercise intervention in… Whole-body Electrical Muscle Stimulation Exercise · PMID 41988780 Myasthénie À vérifier Publication PubMed Voir la publication source Spinal cord injury (SCI) leads to profound muscle atrophy, aerobic deconditioning, and metabolic dysfunction. Exercise-… The Journal of clinical endocrinology and metabolism 2026-09-20 04:37:05 Source
Feasibility and acceptability of whole-body electromyostimulation in… Whole-body Electrical Muscle Stimulation Exercise · PMID 42464389 Myasthénie À vérifier Publication PubMed Voir la publication source Evidence on the effectiveness of electromyostimulation (EMS) has been reported in pulmonary rehabilitation, but the ben… Pilot and feasibility studies 2026-09-20 04:37:05 Source
Vestibular contributions adapt to the balance strategies adopted duri… Whole-body Electrical Muscle Stimulation Exercise · PMID 42616645 Myasthénie À vérifier Publication PubMed Voir la publication source Vestibular contributions during walking are not uniform, but vary with gait phase, muscle group, and balance demands. M… Journal of neurophysiology 2026-09-20 04:37:05 Source
Clinical efficacy of abdominal moxibustion at the Zhongji (CV3) in co… Yangyin Roujin Decoction · PMID 42015783 Myopathies Neuroprotection · Traitement symptomatique Publication PubMed Voir la publication source To investigate the clinical effect of abdominal moxibustion at the Zhongji (CV3) combined with Yiqi Tonglin Yangyin dec… Journal of traditional Chinese medicine = Chung i tsa… 2026-09-20 04:37:03 Source
Yiqi Huoxue Yangyin Decoction Ameliorates Diabetic Nephropathy by Tar… Yangyin Roujin Decoction · PMID 42713045 Myopathies À vérifier Publication PubMed Voir la publication source This study aimed to investigate the protective effects and underlying mechanisms of Yiqi Huoxue Yangyin Decoction (YHY)… Diabetes, metabolic syndrome and obesity : targets and… 2026-09-20 04:37:03 Source
Yiqi Huoxue Yangyin Decoction attenuates diabetic nephropathy in mice… Yangyin Roujin Decoction · PMID 42016924 Myopathies Thérapie génique Publication PubMed Voir la publication source Diabetic nephropathy (DN) is a major complication of diabetes with limited therapeutic options. Yiqi Huoxue Yangyin Dec… Frontiers in pharmacology 2026-09-20 04:37:03 Source
Barcoded oligonucleotide system (BOLT) for targeted organ delivery. Immunotherapy · PMID 42733790 Cancer À vérifier Publication PubMed Voir la publication source The therapeutic potential of oligonucleotides (oligos) is limited by insufficient delivery to extrahepatic tissues. In… Bioactive materials 2026-09-20 04:36:56 Source
Dual metabolic checkpoint blockade a 3D-Printed metalloplatform remod… Immunotherapy · PMID 42724565 Cancer Immunomodulation Publication PubMed Voir la publication source The immunosuppressive tumor microenvironment limits the efficacy of therapies that target metabolism. Here we show a st… Bioactive materials 2026-09-20 04:36:56 Source
Oligosaccharide adjuvant-deferred antigen endocytosis promotes cross-… Immunotherapy · PMID 42751513 Cancer Immunomodulation · Thérapie génique Publication PubMed Voir la publication source Antigen cross-presentation by dendritic cells (DCs) is essential for inducing cytotoxic immune responses, which are cru… Bioactive materials 2026-09-20 04:36:56 Source
Feasibility and safety of early discharge after robot-assisted uro-on… Digital care pathway for hypertension · PMID 42671715 Hypertension artérielle À vérifier Publication PubMed Voir la publication source Early discharge after robot-assisted uro-oncologic surgery remains limited by concerns regarding patient safety and the… Journal of robotic surgery 2026-09-20 04:36:49 Source
HomeSafe: Postpartum Hypertensive Care Enabled by Electronic Health R… Digital care pathway for hypertension · PMID 41707683 Hypertension artérielle À vérifier Publication PubMed Voir la publication source The objective is to present stepwise refinements to , an Epic-tethered, population-health-coordinated postpartum pathwa… American journal of perinatology 2026-09-20 04:36:49 Source
Nutraceutical and functional food: efficacy against metabolic disorde… Digital care pathway for hypertension · PMID 42603698 Hypertension artérielle Neuroprotection · Immunomodulation Publication PubMed Voir la publication source The growing global emphasis on health consciousness has significantly increased demand for traditional and complementar… Journal of advanced research 2026-09-20 04:36:49 Source
Community-engaged design of a virtual diabetes prevention program int… Asynchronous communication with nurse · PMID 42288862 Hypertension artérielle À vérifier Publication PubMed Voir la publication source The Diabetes Prevention Program (DPP) is an evidence-based approach to prevent Type 2 Diabetes (T2D), the leading cause… BMC health services research 2026-09-20 04:36:48 Source
Evolving Lung Cancer Navigator Practice Through Targeted Professional… Asynchronous communication with nurse · PMID 42463006 Cancer À vérifier Publication PubMed Voir la publication source Lung cancer remains the leading cause of cancer deaths worldwide, and it has persistent disparities in detection, treat… Chest 2026-09-20 04:36:48 Source
Mass casualty training for prehospital and emergency providers in Kig… Asynchronous communication with nurse · PMID 42751142 Hypertension artérielle À vérifier Publication PubMed Voir la publication source A mass casualty incident (MCI) occurs when the number of patients exceeds available healthcare resources, placing signi… African journal of emergency medicine : Revue africain… 2026-09-20 04:36:48 Source
Innovating a Teach-Back Model for Community Health Workers Led Health… Health Literacy Project · PMID 40194526 Épilepsie À vérifier Publication PubMed Voir la publication source From 2021 to 2023, the City of Albuquerque, the University of New Mexico (UNM) Office for Community Health, the UNM Hos… Health literacy research and practice 2026-09-20 04:36:34 Source
Carotid intima-media thickness may be an early biomarker for cardiova… Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy · PMID 41026111 Épilepsie À vérifier Publication PubMed Voir la publication source To assess early signs of atherosclerosis following long-term treatment with the ketogenic diet therapy due to concerns… Epilepsia open 2026-09-20 04:36:33 Source
Impact of low-carbohydrate diet on health status: an umbrella review. Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy · PMID 39385794 Cancer À vérifier Publication PubMed Voir la publication source The prevalence of diet-related non-communicable diseases has increased. A low-carbohydrate diet (LCDs) is one of the mo… Frontiers in nutrition 2026-09-20 04:36:33 Source
The effect of anti-seizure medications on lipid values in adults with… Impact of Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy · PMID 37244221 Épilepsie À vérifier Publication PubMed Voir la publication source Certain anti-seizure medications (ASMs) adversely impact lipid values. Here, we explored the impact of ASMs on lipid va… Epilepsy & behavior : E&B 2026-09-20 04:36:33 Source
Possible role of locus coeruleus neuronal loss in age-related memory… The Role of the Locus Coeruleus in Age-related Distractibility · PMID 37694113 Maladie d’Alzheimer Immunomodulation Publication PubMed Voir la publication source Aging is associated with a decline in cognitive abilities, including memory and attention. It is generally accepted tha… Frontiers in neuroscience 2026-09-20 04:36:30 Source
Exploration — prudence

Pistes exploratoires 0

Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.

Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Aucune piste exploratoire ne correspond aux filtres.